Nanophase Technologies Q3 2024 10-Q Filing
Ticker: SLSN · Form: 10-Q · Filed: Nov 12, 2024 · CIK: 883107
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
Nanophase Q3 2024 10-Q is in. Financials for the period ending 9/30/24 are now public.
AI Summary
Nanophase Technologies Corp. reported its Q3 2024 results, ending September 30, 2024. The company's financial performance for the quarter and the first nine months of 2024 is detailed in this 10-Q filing. Specific revenue figures, cost of goods sold, and operating expenses for the periods are presented.
Why It Matters
This filing provides investors and analysts with the official financial performance data for Nanophase Technologies for the third quarter of 2024, enabling informed investment decisions.
Risk Assessment
Risk Level: medium — As a 10-Q filing, it contains detailed financial information which can reveal both positive and negative trends impacting the company's stock.
Key Numbers
- 20240930 — Period End Date (Indicates the end of the reporting quarter.)
- 20241112 — Filing Date (The date the report was officially submitted to the SEC.)
Key Players & Entities
- NANOPHASE TECHNOLOGIES Corp (company) — Filer
- 20240930 (date) — Period of Report
- 20241112 (date) — Filing Date
- 0000883107 (company) — Central Index Key
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended September 30, 2024.
When was this 10-Q filing submitted to the SEC?
This 10-Q filing was submitted to the SEC on November 12, 2024.
What is the Central Index Key (CIK) for Nanophase Technologies Corp?
The Central Index Key for Nanophase Technologies Corp. is 0000883107.
What is the primary SIC code for Nanophase Technologies Corp?
The primary SIC code for Nanophase Technologies Corp. is 2844, which corresponds to Perfumes, Cosmetics & Other Toilet Preparations.
What is the fiscal year end for Nanophase Technologies Corp?
The fiscal year end for Nanophase Technologies Corp. is December 31.
Filing Stats: 4,626 words · 19 min read · ~15 pages · Grade level 15.8 · Accepted 2024-11-12 16:24:57
Filing Documents
- nanx-10q_093024.htm (10-Q) — 769KB
- ex31-1.htm (EX-31.1) — 11KB
- ex31-2.htm (EX-31.2) — 11KB
- ex32.htm (EX-32) — 6KB
- 0001999371-24-014552.txt ( ) — 3791KB
- nanx-20240930.xsd (EX-101.SCH) — 27KB
- nanx-20240930_cal.xml (EX-101.CAL) — 43KB
- nanx-20240930_def.xml (EX-101.DEF) — 91KB
- nanx-20240930_lab.xml (EX-101.LAB) — 205KB
- nanx-20240930_pre.xml (EX-101.PRE) — 167KB
- nanx-10q_093024_htm.xml (XML) — 612KB
– FINANCIAL INFORMATION
PART I – FINANCIAL INFORMATION Item 1.
Financial Statements
Financial Statements 3 Consolidated Balance Sheets (Unaudited Consolidated Condensed) as of September 30, 2024, and December 31, 2023 3 Consolidated Statements of Operations (Unaudited Consolidated Condensed) for the three and nine months ended September 30, 2024, and 2023 4 Consolidated Statements of Shareholders' Equity (Unaudited Consolidated Condensed) for the three and nine months ended September 30, 2024, and 2023 5 Consolidated Statements of Cash Flows (Unaudited Consolidated Condensed) for the nine months ended September 30, 2024, and 2023 6 Notes to Unaudited Consolidated Condensed Financial Statements 7 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 12 Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 15 Item 4.
Controls and Procedures
Controls and Procedures 15
– OTHER INFORMATION
PART II – OTHER INFORMATION 16 Item 1.
Legal Proceedings
Legal Proceedings 16 Item 1A.
Risk Factors
Risk Factors 16 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 16 Item 3. Defaults Upon Senior Securities 16 Item 4. Mine Safety Disclosures 16 Item 5. Other Information 16 Item 6. Exhibits 17
SIGNATURES
SIGNATURES 18 2 PART I – FINANCIAL INFORMATION Item 1. Financial Statements NANOPHASE TECHNOLOGIES CORPORATION CONSOLIDATED BALANCE SHEETS (Unaudited Consolidated Condensed) (in thousands except share and per share data) ASSETS September 30, 2024 December 31, 2023 Current assets: Cash $ 2,925 $ 1,722 Trade accounts receivable, less allowance for credit losses of $ 446 for September 30, 2024, and $ 225 for December 31, 2023 8,732 3,467 Inventories, net 15,043 10,031 Prepaid expenses and other current assets 3,061 1,082 Total current assets 29,761 16,302 Equipment and leasehold improvements, net 10,230 8,668 Operating leases, right of use 8,054 7,907 Other assets, net 2 4 Total assets $ 48,047 $ 32,881 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Lines of credit – accounts receivable, related party $ — $ 2,810 Current portion of line of credit – inventory, related party 5,200 5,000 Current portion of long-term debt, related party 1,000 3,000 Current portion of operating lease obligations 1,091 1,297 Accounts payable 6,562 6,260 Deferred revenue 6,228 2,353 Accrued expenses 3,207 869 Total current liabilities 23,288 21,589 Long-term portion of operating lease obligations 9,346 9,152 Asset retirement obligations 244 238 Total long-term liabilities 9,590 9,390 Shareholders' equity: Preferred stock, $ .01 par value, 24,088 shares authorized on September 30, 2024, and December 31, 2023. No shares issued and outstanding as of September 30, 2024, and December 31, 2023. — — Common stock, $ .01 par value, 95,000,000 and 60,000,000 shares authorized; 69,949,646 and 49,627,254 shares issued and outstanding on September 30, 2024 and December 31, 2023, respectively. 699 496 Additional paid-in capital 114,339 106,069 Accumulated deficit ( 99,869 ) ( 104,663 ) Total shareholders' eq